| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.005 |